Confident low-flow anesthesia
Aisys™ CS² End-tidal Control software
Functionality & FAQs
How it works
Read this summary of how Et Control software functions and the safety mechanisms the system takes to prevent delivering a hypoxic mixture.
Frequently asked questions
Download the FAQs to learn how you can safely practice low-flow anesthesia using Et Control software for automating the delivery of EtO2 and EtAA.
Learn how End-tidal Control operates
Watch this whiteboard video that explains the fundamentals of Et Control software for automatically adjusting fresh gas flow concentrations.
Compare Et Control software to ecoFLOW software
Understand how each software differs and helps support low-flow anesthesia practices.
Clinicians discuss Et Control software
Automation in Anesthesia: First-Ever Technology for US Providers
Watch what clinicians have to say about Et Control software at this 2023 ASA symposium.
OR Sustainability and end-tidal control | ASA 2023
Listen to this Top Med Talk podcast with Dr. David Hovord discussing End-tidal Control and OR sustainability.
Advances in Low-flow Anesthesia: The Path to Automation
Watch an expert panel of clinicians discuss advances in low-flow anesthesia.
End-tidal Control data highlights
Review literature published on the use of Et Control software for automating fresh gas flow concentrations in the operating room.
Footnotes
- Refer to GE HealthCare Et Control Pivotal Study Report DOC2163005. When used as indicated, Et Control is as clinically safe as manual fresh gas control.
- The number 2 footnote has been omitted to avoid any confusion with the Aisys CS2 product name.
- Et Control user’s reference manual (5824844-USA), Et Control Accuracy Graph.
- S. Singaravelu and P. Barclay, Automated control of end-tidal inhalation anaesthetic concentration using the GE Aisys Carestation. British Journal of Anaesthesia 2013; 110 (4): 561–6.
- Tay. S, et al. Financial and environmental costs of manual versus automated control of end-tidal gas concentrations, Anaesthesia Intensive Care 2013; 41: 95-105.
* Et Control in the United States is indicated for patients 18 years of age and older.